Determining the sample size necessary to pass the tentative final monograph pre-operative skin preparation study requirements

Authors

  • Daryl S. Paulson BioScience Laboratories, Inc. 1765 South 19th Avenue, Bozeman, Montana 59718, USA

DOI:

https://doi.org/10.18203/2349-3259.ijct20163952

Keywords:

Statistics, FDA, TFM, Sample size, Clinical trial

Abstract

Predicting the sample size needed to pass the Food and Drug Administration’s current requirements for the preoperative skin preparation can be very difficult.  The purpose of the original FDA formula is detect if the test and positive control products are different and if the test product achieves greater reductions than the control product.  The new Tentative Final monograph includes specific requirements for the lower bounds of the 95% confidence interval and the 70% responder rates.  To meet these requirements, it is important to first conduct a pilot study to determine whether the products will pass the 70% responder rate and then determine the correct sample size correctly to ensure the 95% confidence level is 70% or above.

Author Biography

Daryl S. Paulson, BioScience Laboratories, Inc. 1765 South 19th Avenue, Bozeman, Montana 59718, USA

President and Chief Executive Officer

References

Food and Drug Administration’s Tentative Final Monograph, 1994. Available at http://www.fda.gov/OHRMS/DOCKETS/98fr/94-14503.pdf. Accessed on 10 July 2016.

Ryan TP. Sample Size Determination and Power. Hoboken, NJ: John Wiley & Sons; 2013: 20 – 24.

Velleman PF, Hoaglin DC. Applications, Basics, and Computing of Exploratory Data Analysis. Boston, MA: Duxbury Press; 1981.

Paulson DS. Topical Antimicrobial Testing and Evaluation. 2nd Edition. Boca Raton, FL: CRC Press; 2015: 102 – 104.

PASS Version 14. Available at https://www.statcon. de/shop/en/software/statistics/pass. Accessed on 10 September 2016.

Downloads

Published

2016-10-22